| Serial Number | 86981870 |
| Word Mark | R |
| Filing Date | Monday, February 22, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 17, 2023 |
| Registration Number | 5197060 |
| Registration Date | Tuesday, May 2, 2017 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 26, 2016 |
| Description of Mark | The mark consists of a stylized letter "R" formed by a rectangle with three rounded edges appearing in dark purple at the left, a square with two rounded edges appearing in dark purple at the top, and a square with three rounded edges appearing in light purple on the right. The shapes are all connected at the sharp edges. |
| Pseudo Mark | REVANCE |
| Indication of Colors claimed | The colors dark purple and light purple are claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research related to therapeutic and aesthetic applications of neurotoxins; Measurement evaluations in the field of facial wrinkles and lateral canthal lines; Research and development of drug delivery methods and devices; Conducting and evaluating medical and scientific research and clinical trials in the fields of dermatology |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, March 5, 2016 |
| First Use In Commerce Date | Saturday, March 5, 2016 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Event Date | Event Description |
| Friday, November 17, 2023 | CANCELLED SEC. 8 (6-YR) |
| Monday, May 2, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, May 2, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, March 25, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, March 24, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, March 9, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 8, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, February 22, 2017 | USE AMENDMENT FILED |
| Wednesday, March 8, 2017 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, February 22, 2017 | DIVISIONAL REQUEST RECEIVED |
| Wednesday, March 8, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 22, 2017 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, February 22, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, September 20, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 26, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 26, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 6, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 16, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 13, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Monday, June 13, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, June 13, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Monday, June 13, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 7, 2016 | ASSIGNED TO EXAMINER |
| Saturday, February 27, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, February 26, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 25, 2016 | NEW APPLICATION ENTERED |